Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells

BACKGROUND: Treatment of B-cell malignancies with CD19-directed chimeric antigen receptor (CAR) T-cells marked a new era in immunotherapy, which yet has to be successfully adopted to solid cancers. Epigenetic inhibitors of DNA methyltransferases (DNMTi) and histone deacetylases (HDACi) can induce br...

Descripción completa

Detalles Bibliográficos
Autores principales: Grunewald, Camilla M., Haist, Corinna, König, Carolin, Petzsch, Patrick, Bister, Arthur, Nößner, Elfriede, Wiek, Constanze, Scheckenbach, Kathrin, Köhrer, Karl, Niegisch, Günter, Hanenberg, Helmut, Hoffmann, Michèle J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637820/
https://www.ncbi.nlm.nih.gov/pubmed/34868059
http://dx.doi.org/10.3389/fimmu.2021.782448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637820/
https://www.ncbi.nlm.nih.gov/pubmed/34868059
http://dx.doi.org/10.3389/fimmu.2021.782448

Ejemplares similares